BioStem Technologies, Inc.
BSEM
$4.38
-$0.46-9.60%
OTC PK
| 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 210.39M | 210.39M | 131.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 210.39M | 210.39M | 131.34M |
| Cost of Revenue | -- | -- | 10.86M | 10.86M | 6.94M |
| Gross Profit | -- | -- | 199.54M | 199.54M | 124.39M |
| SG&A Expenses | -- | -- | 177.73M | 177.73M | 112.94M |
| Depreciation & Amortization | -- | -- | 217.40K | 217.40K | 216.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 189.78M | 189.78M | 120.63M |
| Operating Income | -- | -- | 20.61M | 20.61M | 10.70M |
| Income Before Tax | -- | -- | 19.45M | 19.53M | 8.76M |
| Income Tax Expenses | -- | -- | 5.83M | 5.83M | 3.50M |
| Earnings from Continuing Operations | -- | -- | 13.62 | 13.70 | 5.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | 13.62M | 13.70M | 5.26M |
| EBIT | -- | -- | 20.61M | 20.61M | 10.70M |
| EBITDA | -- | -- | 20.83M | 20.83M | 10.92M |
| EPS Basic | -- | -- | 0.82 | 0.83 | 0.29 |
| Normalized Basic EPS | -- | -- | 0.77 | 0.77 | 0.38 |
| EPS Diluted | -- | -- | 0.61 | 0.61 | 0.18 |
| Normalized Diluted EPS | -- | -- | 0.59 | 0.59 | 0.28 |
| Average Basic Shares Outstanding | -- | -- | 64.14M | 64.14M | 61.31M |
| Average Diluted Shares Outstanding | -- | -- | 76.57M | 77.01M | 68.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |